HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial epilepsy: a cross-sectional nationwide Italian survey.

Abstract
Many aspects of epilepsy in mitochondrial disorders (MDs) need to be further clarified. To this aim, we explored retrospectively a cohort of individuals with MDs querying the "Nationwide Italian Collaborative Network of Mitochondrial Diseases" (NICNMD) database (1467 patients included since 2010 to December 2016). We collected information on age at epilepsy onset, seizure type and frequency, genetic findings, and antiepileptic drugs (AEDs). At the time of our survey, 147/1467 (10%) patients in the NICNMD database had epilepsy. Complete information was available only for 98 patients, 52 males and 46 females, aged 5-92 years (mean age 40.4 ± 18.4; 14/98 children/teenagers and 84 adults). Epilepsy was the presenting feature of MD in 46/98 (47%) individuals, with onset at a median age of 19 years (range, 0.2-68; < 3 years in 14/97 (14%), 3-19 years in 36/97 (37%), > 19 years in 47/97 (49%)). Moreover, 91/98 patients (93%) displayed multiple seizures, with daily or weekly frequency in 25/91 (28%). Interictal EEG was abnormal in 70/78 (90%) patients, displaying abnormal background (47/70; 67%) and/or interictal paroxysms (53/70; 76%). Eighty of 90 patients (89%) displayed a 50-100% reduction of seizures on AEDs; levetiracetam was the most commonly used. Forty-one patients (42%) carried the m.3243A>G mutation, 16 (16%) the m.8344A>G, and 9 (9%) nuclear DNA (nDNA) mutations. Individuals with early-onset seizures mainly carried nDNA mutations and had a more severe epilepsy phenotype, higher seizure frequency, and disorganized background EEG activity. A better definition of epilepsy in MDs may foster the diagnostic workup, management, and treatment of affected patients, and allow more homogeneous patient stratification.
AuthorsChiara Ticci, Federico Sicca, Anna Ardissone, Enrico Bertini, Valerio Carelli, Daria Diodato, Lidia Di Vito, Massimiliano Filosto, Chiara La Morgia, Costanza Lamperti, Diego Martinelli, Isabella Moroni, Olimpia Musumeci, Daniele Orsucci, Elia Pancheri, Lorenzo Peverelli, Guido Primiano, Anna Rubegni, Serenella Servidei, Gabriele Siciliano, Costanza Simoncini, Paola Tonin, Antonio Toscano, Michelangelo Mancuso, Filippo M Santorelli
JournalNeurogenetics (Neurogenetics) Vol. 21 Issue 2 Pg. 87-96 (04 2020) ISSN: 1364-6753 [Electronic] United States
PMID31900734 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Epilepsy (complications, epidemiology)
  • Female
  • Humans
  • Italy (epidemiology)
  • Male
  • Middle Aged
  • Mitochondrial Diseases (complications, epidemiology)
  • Retrospective Studies
  • Seizures (complications, epidemiology)
  • Surveys and Questionnaires
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: